Please select
your location below

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

By selecting the International view, you verify that you reside outside of the USA and you wish to view Diasorin's International Product Information.
This material is intended for International (non-USA) site visitors only.

Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professional operators.

LIAISON PLEX^® Yeast Blood Culture Assay

Optimize Treatment in Hours—Not Days

The LIAISON PLEX^® Yeast Blood Culture Assay integrates with your standard-of-care workflow for maximum clinical impact through the molecular detection and differentiation of up to 16 pathogens frequently found to cause fungemia.

Learn more now

LIAISON PLEX<sup>®</sup> Yeast Blood Culture Assay

Disease state

Sepsis is the leading cause of mortality in US hospitals, with over 1.7 million cases diagnosed annually.¹ Delays in optimal treatment significantly increase the risk of mortality, with estimates indicating a 7.6% rise in fatality rates for each hour of delay.² The financial burden of acute sepsis hospitalization is substantial, with annual costs estimated at $62 billion.³

Gram-positive bacteremia accounts for approximately 60% of all positive blood cultures. Invasive gram-positive bacteremia often requires therapeutic adjustments from more generalized empiric therapy.⁴

_{1. http://dx.doi.org/10.15585/mmwr.mm7234a2}
_{2. https://doi.org/10.3390/antibiotics11091202}
_{3. https://www.sepsis.org/education/resources/fact-sheets/}
_{4. https://pubmed.ncbi.nlm.nih.gov/37097814/}

Fungemia can lead to sepsis, which has a high mortality rate.

The value of LIAISON PLEX^® Yeast Blood Culture Assay

Empower clinicians to rapidly optimize treatment for fungemia.

Clinical impact

Comprehensive pathogen and resistance gene coverage enhances diagnostic accuracy, empowering informed decisions to optimize patient management while also reinforcing antimicrobial stewardship—ultimately aiding in the fight against bloodstream infections and sepsis.

Outstanding economic value

Designed for seamless workflow integration, the Gram stain-based panel selection enhances diagnostic stewardship while optimizing operational costs.

The right assay design

PCR-based molecular chemistry detects 16 yeast pathogens frequently found in fungemia.

How LIAISON PLEX^® Yeast Blood Culture Assay works

The LIAISON PLEX^® Yeast Blood Culture Assay is a syndromic in vitro diagnostic test for the detection and identification of invasive pathogenic yeast. Subculturing is necessary for susceptibility testing and identification of organisms not detected by the assay.

Transfer sample

Transfer sample to cartridge.

Scan

Scan the Sample ID and the Cartridge ID.

Load and run

Load the cartridge, initiate the Run, and walk away.

Indications for LIAISON PLEX^® Yeast Blood Culture Assay use

Assay and system

An automated, multiplex PCR assay run on the LIAISON PLEX^® System to detect and identify 16 yeast pathogens, including the one of the most relevant pathogen today: Candida auris.

Patient types

Patients with a positive blood culture bottle and Gram stain indicating a fungal organism may be present.

Diagnostic Lab

Hospital, commercial reference, and/or public health laboratories.